FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37122311000001100: Mometasone 50micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-May 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
173281000001110 Mometasone 50micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
173291000001112 Mometasone 50micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mometasone 50micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) Is a Mometasone 50micrograms/dose nasal spray false Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) Has dispensed dose form Spray dose form true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Mometasone furoate true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) Is a Mometasone 50micrograms/dose nasal spray true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) Is a Mometasone furoate monohydrate 0.05% aqueous nasal spray false Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Mometasone 50micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) 140 dose Has AMP True Mometasone 50micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start